Neuro Resus - podcast cover

Neuro Resus

Oliver Flower•www.neuroresus.com
Health & Fitness
Medicine
Education
Podcasts on topics relevant to intensive care medicine
Last refreshed: ⓘ
Follow this podcast in the Metacast mobile app to refresh it and see new episodes.
Follow on
Apple Podcasts
Spotify
RSS
YouTube
Overcast
Pocket Casts
Episodes.fm
Download Metacast podcast app
Podcasts are better in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more

Episodes

Trauma by Remote

Professor Chad Ball: Trauma by Remote. From CICM ASM PROGRAM 2019

Aug 08, 2019•24 min

Remote Trauma

Dr John O’Neill: Remote Trauma. From CICM ASM PROGRAM 2019

Aug 07, 2019•32 min

Why do we need a NCCTRC?

Associate Professor Dianne Stephens: Why do we need a NCCTRC? From CICM ASM PROGRAM 2019

Aug 06, 2019•22 min

ECMO

Associate Professor Samuel Galvagno: ECMO. From CICM ASM PROGRAM 2019

Aug 01, 2019•28 min

REBOA

Professor Mark Midwinter: REBOA. From CICM ASM PROGRAM 2019

Jul 31, 2019•23 min

RAPTOR

Professor Chad Ball: RAPTOR. From CICM ASM PROGRAM 2019

Jul 30, 2019•29 min

Immune diseases - What about all those MABs

Monoclonal antibodies (MAbs), guided by molecular studies and personalised medicine are changing the face of clinical medicine. They hold the promise of controlling diseases and improving survival whilst reducing the side effects of some ‘traditional’ therapies. MAbs are being used in conditions familiar to intensivists such as asthma, invasive candidiasis, RSV infection, reversal of novel anticoagulants and clostridium difficile infection as well as in those less commonly seen by intensivists s...

Oct 10, 2018•28 min

Malignancy

The incidence of cancer is increasing in line with our ageing population, with a greater number of patients requiring ICU admission for support managing complications of their malignancy, it’s therapy, or conditions unrelated to their underlying cancer. Despite these indications, the presence of a cancer diagnosis has been a common reason for refusal of ICU admission, or admission with treatment limitations. This session will present the current epidemiology, characteristics and outcomes of pati...

Oct 10, 2018•26 min

Massive Stroke

There have been significant developments in the diagnosis and management of ischaemic stroke. This started with trials showing a benefit for decompressive craniectomy after a malignant hemispheric stroke in patients under 60 undergoing surgery within 48 hours. The evolution of CT and MRI have enabled us to better image not only the ischaemic core of the stroke, but also the surrounding hypo-perfused brain at risk of ischaemic death; the penumbra. CT and MR angiography now allow rapid, non-invasi...

Oct 10, 2018•21 min

HIV and Hepatitis C

People living with HIV in 2018 now have normal life expectancy if receiving Anti-Retroviral Therapy (ART) and often require only one co-formulated pill every day to remain well. However there are still people living with HIV who are unaware of their diagnosis; who may present with a critical illness. Knowing who to test is essential. The population living with HIV are also ageing and often have comorbidities. It is vital that clinical conditions associated with HIV are recognised and for those r...

Oct 10, 2018•22 min

Blood Pressure Targets

Blood Pressure (BP) is one of the vital hemodynamic parameters that we often aim to optimize for critically ill patients. Our decisions regarding BP targets, and ensuing use (or avoidance) of vasopressor agents, may directly impact on outcomes for these patients. Despite being a fundamental tenet of critical care, there is a lack of quality evidence to suggest optimal BP targets or to guide the use of vasopressors for individual patients with shock. A mean arterial BP (MAP) of 65-70 mmHg is an o...

Oct 10, 2018•21 min

Diabetes Management: new drugs and new approaches

Recently, several novel glucose-lowering targets have had drugs developed. This has resulted in several new drugs that have been approved for the local market to treat hyperglycaemia in patients with type 2 diabetes. This presentation will attempt to provide: A concise summary of these drugs for an Intensive Care Physician. A pragmatic framework for what the non-Endocrinology Doctor should do with these drugs whilst the patient is in, and being discharged from, the Intensive Care Unit. An outlin...

Oct 10, 2018•22 min

Frailty: a better reflection of long term outcome?

Frailty is a state of reduced physical, physiological and cognitive reserve. Tools to measure frailty which were developed in geriatric medicine practice, have over recent years been applied to patients admitted to the Intensive Care Unit (ICU). Studies in the ICU suggest that frailty is associated with reduced reduced likelihood of discharge home and reduced survival at one year. Survivors also report lower quality of life measures on both physical and mental assessments. The most common of fra...

Oct 10, 2018•16 min

Training and QA for your regional unit

International outcomes of centres performing ECLS (extracorporeal life support) are highly variable due to differences in patient selection, cannulation technique, practitioner experience and hospital volume. We describe the experience of one of the first regional intensive care units in Australia to provide both VV (veno-venous) and rescue VA ECMO (veno-arterial extra-corporeal membrane oxygenation). Methods Review of internal registry and description of processes and procedures in an 11 bed re...

Sep 25, 2018•18 min

Coordinating an ECMO service with retrieval

Since the H1N1 influenza pandemic of 2009 there has been a dramatic increase in the number of patients receiving ECMO and in the number of hospitals that provide it. Data from the Extracorporeal Life Support Organisation (ELSO) suggests that over the last decade the number of adult patients receiving ECMO for respiratory support has increased at least 12-fold and the number of centres submitting data to the ELSO registry has tripled. The approach to the provision of ECMO in NZ and Australia has ...

Sep 25, 2018•21 min

Extracorporeal Membrane Oxygenation (ECMO) for all?

I will consider this question in two parts; Should ECMO be considered for all patients? Should ECMO services be provided in all ICUs? From a patient perspective, ECMO is a highly invasive intervention and like every other intervention that we consider, the benefits it provides must outweigh its risks for it to be worthwhile. Clearly, veno-venous and veno-arterial ECMO supports are very different beasts – the patient profile, physiology, complications and outcomes differ considerably. At the extr...

Sep 24, 2018•22 min

VAD & transplanted patient with non-cardiac critical illness

Use of Ventricular Assist Devices (VAD) and heart transplantation (HT) for end stage cardiac failure have increased significantly in recent decades. These support strategies hold inherently different risks in the face on non-cardiac critical illness, and require multidisciplinary team management. According to INTERMACS, more than 2500 VADs/year are implanted the USA. Most implanted devices are continuous flow left-VADs (75%) which deliver systemic cardiac output directly related to pump speed an...

Sep 19, 2018•18 min

Transplant or durable mechanical support

Both cardiac transplantation and durable mechanical support with ventricular assist devices (VADs) have a parallel history – poor results to begin with followed by progressively improving results with more targeted immunosuppression, better recipient selection, improved diagnosis and treatment of rejection and opportunistic infections (cardiac transplantation) and a major step forward with replacement of pulsatile pumps by continuous flow devices (VADs). Heart transplantation continues to be reg...

Sep 19, 2018•22 min
← PrevNext →
Hosted on Libsyn
For the best experience, listen in Metacast app for iOS or Android